Five Questions with Accelmed managing partner Uri Geiger

Accelmed looks to stand out by investing in US-based HealthTech companies that are unlikely to appeal to the traditional private equity fund, taking advantage of its Israel-based team that sources add-ons.

DealsPeopleHealthcareFeaturedTop Stories